Page 12 - Genomics Using Convolutional Networks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genomics using convolutional networks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genomics Using Convolutional Networks Today - Breaking & Trending Today

ACMG releases new Points to Consider statement on the clinical utility of polygenic risk scores for embryo selection

Should we be using polygenic risk score assessment for embryo selection? Providing in-depth analysis, the Social, Ethical and Legal Issues Committee of the American College of Medical Genetics and Genomics (ACMG) has released a new Points to Consider statement to assist healthcare professionals and patients in understanding the safety and utility of preimplantation genetic testing for polygenic disorders (PGT-P) as a clinical service. ....

Susan Klugman , Theresaa Grebe , American College Of Medical Genetics , Medical Genetics , Legal Issues Committee , American College , Polygenic Risk Scores , Embryo Selection , Consider Statement , Cardiovascular Disease , N Vitro , Public Health ,

All of Us: 413,000 genomes across ancestries, ages, socioeconomics

Since its founding by the National Institutes of Health (NIH), the scientists of the All of Us Research Program have set the goal to analyze the largest diversity of the genomic population in the country and end the under-representation of its different groups. The project has expanded the vision of several pathologies, discovered thousands of new genetic variants, redefined the risk genes for common diseases, and stratified them, uncovering eight different forms in the case of type 2 diabetes (T2D). Their results create a pathway for a new age of precision medicine. ....

National Institutes Of Health , Us Research Program , National Institutes , Bioworld Science , All Of Us , Underrepresented Population , Polygenic Risk Scores , Type 2 Diabetes , Precision Medicine , Drug Design , Rug Delivery And Technologies ,

NIFTY® DNBSEQ-G99 Platform Receives CE-IVDD Certification And Advances Prenatal Care Standards

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD certification to include the DNBSEQ-G99 model to meet the European Union regulations for medical devices. ....

Saudi Arabia , United Kingdom , European Union , Medical Devices , Precision Medicine ,